According to research presented by Dr. Teressa Quattrin at the Jacobs School of Medicine and Biomedical Sciences, treatment with golimumab resulted in better endogenous insulin production in patients with type 1 diabetes.Type 1 diabetes is an autoimmune disease characterized by the progressive loss of pancreatic beta cells to make insulin. …
Read More »Findings for modest increases in light-intensity and moderate-to-vigorous activity among adults with metabolic syndrome
Read More »Lifestyle intervention effective in reducing age-adjusted occurrence of GDM only among those with the highest genetic risk for type 2 diabetes
Read More »Each doubling of serum perfluorooctanoate, overall PFAS/phthalate mixture linked to lower areal BMD in male adolescents
Read More »For those aged 35 years with BMI of 25 kg/m2, prevalence of diabetes significantly higher for racial/ethnic minorities versus Whites
Read More »Disparities in T1D outcomes seen for Black children compared with Hispanic, White children from neighborhoods with similar opportunity levels
Read More »Evidence from phase 2 trial suggests positive effects on cognition and gait in elderly patients with type 2 diabetes
Read More »
According to research presented by Dr. Tong Yew at the National University Hospital in Singapore, smartphone coaching in conjunction with usual care resulted in better maternal glycemic control. Gestation diabetes mellitus (GDM) affects around 25% of all pregnancies in Singapore. Cesarean section, preeclampsia, preterm labor, macrosomia, and infant hypoglycemia can …
Read More »
Will this standard type 2 diabetes treatment change the treatment choice for patients with gout? Sodium-glucose transport protein 2 (SGLT-2) inhibitors are a staple in treating patients with type 2 diabetes. These drugs were designed for use in patients with type 2 diabetes. It reduces blood glucose levels by helping excrete …
Read More »Direct effect of body size validated using data from meta-analysis including 15,573 cases and 158,408 controls
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.